Active Ingredient History

NOW
  • Now
LASMIDITAN is a serotonin (5-HT) receptor agonist without vasoconstrictor activity, which selectively binds to the 5-HT(1F) receptor subtype. It is under development for the treatment of migraine.   NCATS

  • SMILES: CN1CCC(CC1)C(=O)C2=CC=CC(NC(=O)C3=C(F)C=C(F)C=C3F)=N2
  • InChIKey: XEDHVZKDSYZQBF-UHFFFAOYSA-N
  • Mol. Mass: 377.3603
  • ALogP: 3.28
  • ChEMBL Molecule:
More Chemistry

Drug Pricing (per unit)

United States

$59.7075 - $80.9424
More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

2,4,6-trifluoro-n-(6-((1-methylpiperidin-4-yl)carbonyl)pyridin-2yl)benzamide | col-144 | lasmiditan | lasmiditan hydrochloride | ly573144 | ly-573144

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue